ProfileGDS5822 / ILMN_2832802
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 27% 2% 6% 15% 14% 28% 20% 5% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.627
GSM1276600PDAC Late Ablation Control 27.72
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 17.36
GSM1276603PDAC Late Ablation 210.515
GSM1276604PDAC Late Ablation 39.914
GSM1303940PDAC Late Ablation_anti-CTLA4 114.828
GSM1303941PDAC Late Ablation_anti-CTLA4 210.820
GSM1303942PDAC Late Ablation_anti-CTLA4 34.25